Therapeutic targeting of metabolic synthetic lethality in cancer research

C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

In this webinar, Dr. Yuting Sun discusses her research supporting a Phase 1 clinical trial advancing cancer therapies, targeted at metabolic vulnerabilities. Metabolic rewiring is a hallmark of cancer. However, the plasticity of preexisting regulatory circuit compromises the effectiveness of targeted therapies. We postulate that leveraging genetic vulnerabilities in cancer cells may overcome such adaptations. In this presentation, we discuss strategies in targeting two distinct metabolic vulnerabilities- FHmut cancer and glycolysis-deficient cancer.

 

Learning Objectives:

1. Targeting redox balance in FHmut cancer

2. Targeting OXPHOS in glycolysis deficient tumor

3. Utilization of seahorse assay supporting Phase 1 clinical trial (for research use)


Show Resources
You May Also Like
FEB 19, 2020 11:00 AM PST
C.E. CREDITS
FEB 19, 2020 11:00 AM PST
DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
JUN 17, 2020 1:30 PM PDT
C.E. CREDITS
JUN 17, 2020 1:30 PM PDT
Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
MAR 11, 2020 6:00 AM PDT
C.E. CREDITS
MAR 11, 2020 6:00 AM PDT
The locomotion of humans and other animals requires a seamless flow of information from sensory modalities all the way to the motor periphery. As such, locomotion is an excellent system for...
APR 30, 2020 8:00 AM PDT
C.E. CREDITS
APR 30, 2020 8:00 AM PDT
DATE:April 30, 2020 TIME: 8AM PT, 11AM ET, 4PM BST, 5PM CEST Cytokinesis is the physical separation of two cells that occurs after the completion of mitosis. The mechanism underlying it is v...
APR 07, 2020 8:00 AM PDT
C.E. CREDITS
APR 07, 2020 8:00 AM PDT
DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
AUG 26, 2020 8:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
AUG 26, 2020 8:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
DATE: August 26, 2020 TIME: 8:00 am PDT The host immune "recognition" of cancer forms the basis of modern tumor immmunotherapy, a highly targeted treatment option with the demonstr...
Loading Comments...
Show Resources